There is No Association between Cardiovascular Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis Patients by Stamboulis, Elefterios et al.
Copyright © 2010 Korean Neurological Association  143
Print ISSN 1738-6586 / On-line ISSN 2005-5013
10.3988/jcn.2010.6.3.143
ORIGINAL ARTICLE
J Clin Neurol 2010;6:143-147
There is No Association between Cardiovascular 
Autonomic Dysfunction and Peripheral Neuropathy 
in Chronic Hemodialysis Patients
Elefterios Stamboulis, MD
a; Konstantinos Voumvourakis, MD
a; Thomas Zambelis, MD
b; Athina Andrikopoulou, MD
a;
Demetrios Vlahakos, MD
c; Athanasios Tsivgoulis, MD
a; Demetrios Rallis, MD
b; Georgios Tsivgoulis, MD
a,d
aSecond Department of Neurology, Attikon Hospital, University of Athens, Athens, Greece
bFirst Department of Neurology, Aeginition Hospital, University of Athens, Athens, Greece
cSecond Department of Medicine, Renal Unit, Attikon Hospital, University of Athens, Athens, Greece
dDepartment of Neurology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece
Received	 December 12, 2009
Revised	 April 12, 2010
Accepted	 April 12, 2010
Correspondence
Georgios Tsivgoulis, MD
Second Department of Neurology,
Attikon Hospital, 
University of Athens, 
Iras 39, Athens 15344, Greece
Tel    +30-69-371786355
Fax   +30-21-07251622
E-mail    tsivgoulisgiorg@yahoo.gr
Background and PurposezzThe potential association between the severity of autonomic dys-
function and peripheral neuropathy has not been extensively investigated, with the few studies 
yielding inconsistent results. We evaluated the relationship between autonomic dysfunction and 
peripheral neuropathy in chronic hemodialysis patients in a cross-sectional study.
MethodszzCardiovascular autonomic function was assessed in 42 consecutive patients with ch-
ronic renal failure treated by hemodialysis, using a standardized battery of 5 cardiovascular reflex 
tests. Symptoms of autonomic dysfunction and of peripheral neuropathy were evaluated using the 
Autonomic Neuropathy Symptom Score (ANSS) and the Neuropathy Symptoms Score. Neurolo-
gical deficits were assessed using the Neuropathy Disability Score. Conduction velocities along 
the sensory and motor fibers of the sural and peroneal nerves were measured. Thermal thresholds 
were documented using a standardized psychophysical technique.
ResultszzParasympathetic and sympathetic dysfunction was prevalent in 50% and 28% of cases, 
respectively. Peripheral neuropathy was identified in 25 cases (60%). The prevalence of periph-
eral neuropathy did not differ between patients with impaired (55%) and normal (75%) auto-
nomic function (p=0.297; Fisher’s exact test). The electrophysiological parameters for peripheral 
nerve function, neuropathic symptoms, abnormal thermal thresholds, age, gender, and duration of 
dialysis did not differ significantly between patients with and without autonomic dysfunction. 
Patients with autonomic dysfunction were more likely to have an abnormal ANSS (p=0.048). The 
severity of autonomic dysfunction on electrophysiological testing was positively correlated with 
ANSS (r=0.213, p=0.036).
ConclusionszzThe present data indicate that although cardiovascular autonomic dysfunction is 
prevalent among patients with chronic renal failure, it is not associated with the incidence of pe-
ripheral neuropathy.  J Clin Neurol 2010;6:143-147
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Introduction
Autonomic dysfunction in patients with chronic renal failure 
(CRF) has been well-documented using a variety of simple, 
sensitive, reproducible, and noninvasive tests.
1-14 Conserva-
tively treated patients have been reported as having more-se-
vere autonomic nervous system (ANS) disturbances, which 
improved after the onset of hemodialysis.
1,15 In contrast, other 
authors found that the severity of autonomic dysfunction did 
not differ significantly between those treated conservatively, 
those on continuous ambulatory peritoneal dialysis, and those 
on intermittent hemodialysis.
4,7 Interestingly, come investiga-
tors have found a positive association between the severity 
of autonomic function and the severity of uremia,
7 while oth-Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis
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ers found no such relationship.
8 Moreover, some studies have 
found that the total length of time on hemodialysis was not 
correlated with the incidence and severity of autonomic dys-
function in CRF patients.
2,4
To the best of our knowledge, the potential association be-
tween the severity of autonomic dysfunction and peripheral 
neuropathy has not been investigated extensively, with the 
few studies yielding inconsistent results. In the present cross-
sectional study we aimed to determine the cardiovascular (CV) 
autonomic function in patients on chronic hemodialysis and 
whether there is a correlation between autonomic dysfunction 
and large- and small-fiber neuropathy.
Methods
We examined a consecutive series of patients with end-stage 
renal failure on chronic hemodialysis. The causes of renal fail-
ure were chronic glomerulonephritis, polycystic kidney disease, 
and reflux nephropathy. Patients with class III or IV heart fail-
ure (according to the New York Heart Association Functional 
Classification),
16 severe hypertension [systolic blood pressure 
(SBP) ≥160 mmHg and/or diastolic blood pressure (DBP) 
≥100 mmHg], ischemic cardiopathy (history of myocardial 
infarction or coronary artery bypass graft, or coronary stent-
ing), diabetes mellitus, bronchopneumopathy, and amyloido-
sis were excluded. Patients taking drugs known to affect the 
ANS (e.g., beta-blockers, sympatheticomimetics, tricyclic an-
tidepressants, and anticholinergics) were not included in the 
present investigation.
All patients were examined on a dialysis-free day. The clini-
cal evaluation of neuropathy symptoms was conducted using 
the Neuropathy Symptoms Score (NSS).
17,18 The NSS evalu-
ates several motor and sensory symptoms revealed by the neu-
rological history. Autonomic symptoms were assessed by the 
Autonomic Neuropathy Symptom Score (ANSS), which eval-
uates the following symptoms: postural hypotension, diarrhea, 
impotence in men, and reduced sweating.
19 An NSS of >1 or an 
ANSS of >1 was considered to be abnormal.
19
Neurological deficits were evaluated using the neuropathy 
disability score (NDS),
17 which is a summed score of selected 
individual items from the neurological examination of mus-
cle weakness, activity of tendon reflexes (hyper-reflexia was 
not graded), and assessment of sensation on the index finger 
and great toe. An NDS of >2 (a score of >1 from each side) 
was considered abnormal.
18
The CV autonomic tests were performed with the patients 
having no history of acute illness for the preceding 48 h and 
unaccustomed vigorous exercise for the preceding 24 h. The 
patients were instructed to avoid consuming food, caffeine, 
or tobacco products for the 8 h immediately preceding the au-
tonomic testing. The studies were performed in the morning 
in a relaxed environment, as described previously.
19,20 The bat-
tery of five autonomic tests included three for parasympa-
thetic function [heart rate (HR) responses to the Valsalva ma-
neuver, deep breathing, and standing] and two for sympathetic 
function [blood pressure (BP) responses to standing and to a 
sustained hand grip].
During the deep-breathing test the patients were trained to 
breathe deeply at a rate of 6 breaths/min while in the supine 
position. The HR was then monitored continuously on an EMG 
machine at a paper speed of 25 mm/s for 1 min. The changes 
in HR are expressed as the mean of the differences between 
the maximal and minimal HR during six successive breaths. 
A normal response is a difference of 15 beats/min or more, be-
ing abnormal when less than 10 beats/min and borderline 
when between 10 and 14 beats/min.
During the Valsalva-maneuver testing, patients were requir-
ed to blow into a syringe and maintain the pressure in an an-
aeroid manometer at about 40 mmHg for 10 s while the HR 
was recorded in a supine position. The Valsalva ratio was cal-
culated as the ratio of longest R-R interval after the maneu-
ver to the shortest R-R interval during the maneuver. A value of 
1.10 or less was defined as an abnormal response, 1.11-1.20 as 
a borderline response, and 1.21 or more as a normal response.
The BP and HR responses to standing were evaluated as 
follows. After 15 min of supine rest, the BP was recorded 
twice. The patient was then asked to stand quickly and to re-
main motionless for 2 min. During this time, the BP was re-
corded at 30-s intervals. Changes in BP were calculated as the 
difference between the mean resting and the standing values. 
Postural hypotension was defined as a fall in SBP of 30 mmHg 
or more and/or a fall in DBP of 15 mmHg or more. The test 
result was considered to be normal when the fall in SBP was 
no more than 10 mmHg and borderline when it ranged be-
tween 11 and 29 mmHg. The HR was continuously monitored 
during and after standing at a chart speed of 25 mm/s. The 
30/15 ratio was calculated as the ratio of the R-R interval at 
beat 30 after standing to that at beat 15. A value of 1 or less was 
defined as an abnormal response, 1.01-1.02 as a borderline re-
sponse, and 1.04 or more as a normal response.
The sustained hand-grip test was performed as follows. The 
patient was asked to exert 30% of the maximal voluntary con-
traction for 3 min on a hand-grip dynamometer using the arm 
without fistula. The BP was measured in the nonexercising 
arm at rest and at 60-s intervals during the test. The highest 
increase in DBP was documented. A rise in DBP of <10 mm 
Hg was defined as abnormal, 10-15 mmHg as borderline, and 
>15 mmHg as normal.
The results of the tests were analyzed in two ways: 1) accord-
ing to the severity of damage
21 by grouping the results into “nor- Stamboulis E et al.
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mal”, “early parasympathetic damage” (one abnormal or two 
borderline HR tests), “definite parasympathetic damage” (two 
or more abnormal HR tests), “additional sympathetic damage” 
(two abnormal HR tests plus one or two abnormal BP tests), 
“early sympathetic damage” (one abnormal or two borderline 
BP tests), and “uncertain” (any other combination of border-
line tests); and by adding the results of all five function tests 
(with 0 for normal, 1 for borderline, and 2 for abnormal) and 
computing a composite autonomic score ranging from 0 to 
10.
4 Seven patients were unable to perform all tests (Valsalva 
maneuver in one, postural HR in one, BP in four, hand grip 
in five, and deep breathing in two).
Nerve conduction studies
The same investigator performed the electrophysiological 
studies in all patients, and standard procedures were used as de-
scribed previously.
22,23 Motor nerve conduction studies (NCSs) 
of the right ulnar and peroneal nerves were performed. Sur-
face electrode recordings were obtained from the abductor di-
giti minimi and the extensor digitorum brevis. Antidromic sen-
sory NCSs of the right ulnar and sural nerves were also per-
formed. Measurements were taken at temperatures of 32ºC 
and 29ºC for the upper and lower limbs, respectively. Devia-
tions of two standard deviations (SDs) or more relative to the 
mean values of the controls were considered abnormal (in 
median distal motor latency/motor conduction velocity or in 
median sensory latency to peak/sensory conduction velocity). 
Electrophysiological studies were repeated in the left upper 
and lower limbs of patients with abnormal right peroneal and 
ulnar NCS results, and the initial diagnosis of peripheral neu-
ropathy was confirmed in all cases.
Finally, the patients’ threshold for the detection of warm and 
cold in the foot were assessed in a forced-choice psychophysi-
cal test using a microprocessor-controlled thermode that was 
based on the Peltier principle.
24 The amplitude of the temper-
ature change was determined by the subjects’ response to the 
preceding stimulus using the “up-and-down transformed re-
sponse rule”. The thermal thresholds were compared with those 
of age- and gender-matched healthy controls who had no cli-
nical evidence of neuropathy. Thermal thresholds were con-
sidered abnormal if they exceeded the normal mean by more 
than two SDs.
Statistical analyses 
Comparisons were performed using the χ2-test, Fisher’s ex-
act test, unpaired t-test, and Mann-Whitney U-test as indicat-
ed. Potential associations were evaluated using Spearman’s 
correlation coefficient (r) and linear regression models. The 
Statistical Package for Social Sciences (SPSS, version 10.0 
for Windows, SPSS Inc., Chicago, IL, USA) was used for 
statistical analyses.
Results
In total, 42 patients (18 males and 24 females) with end-stage 
renal failure aged 16-70 years (age 46±13 years, mean±SD) 
were studied. All patients had been receiving dialysis for 4 h 
three times a week for a period ranging from 2 months to 19 
years (duration 5.3±3.8 years). The findings of all CV autono-
mic tests are presented in Table 1. Parasympathetic and sym-
pathetic dysfunction was prevalent in 50% and 28% of cases, 
respectively, while both sympathetic and parasympathetic 
functions were affected in 62% of the study population. The 
severity of autonomic dysfunction is presented in Table 2. The 
median composite autonomic function score was 2 (interquar-
tile range 3) in patients with abnormal autonomic function.
The age (p=0.434) and duration of dialysis (p=0.547) did 
not differ between patients with normal and abnormal auto-
nomic function. The prevalence of autonomic dysfunction in 
different groups of patients stratified according to the electro-
physiological and clinical assessments is presented in Table 
3. Peripheral neuropathy was identified in 25 cases (60%). 
The prevalence of peripheral neuropathy did not differ be-
tween patients with impaired (55%) and normal (75%) auto-
nomic function (p=0.297, Fisher’s exact test). The electro-
physiological parameters for peripheral nerve function, 
Table 1. Autonomic function tests of the study population
Patients Normal Borderline Abnormal
Valsalva ratio 41 38 02 01
Maximum–minimum heart rate 40 29 06 05
30 : 15 ratio 41 21 06 14
BP response to standing 38 19 12 07
BP response to sustained hand-grip test 37 24 09 04
BP: blood pressure.
Table 2. Severity of autonomic damage
Category n % Score
Normal 12 29 0
Early parasympathetic 12 29 2-5
Definite parasympathetic 02 05 4
Additional sympathetic 07 16 4-6
Early sympathetic 05 12 2
Uncertain 04 09 1Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis
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neuropathic symptoms, abnormal thermal thresholds, age, 
gender, and duration of dialysis did not differ significantly 
between patients with and without autonomic dysfunction. 
Patients with autonomic dysfunction had a higher prevalence 
of abnormal ANSS (p=0.048). We found no association be-
tween NSS or NDS neuropathic symptoms and severity of 
autonomic dysfunction (p>0.2). The severity of autonomic 
dysfunction on electrophysiological testing was positively 
correlated with ANSS (r=0.213, p=0.036) but not with age 
(r=0.058, p=0.419).
Discussion
Our study shows that autonomic dysfunction is prevalent in 
patients with CRF on hemodialysis. However, the incidence 
of autonomic dysfunction is unrelated to the presence of large- 
or small-fiber neuropathy. In addition, we found no associa-
tion between the severity of autonomic dysfunction and the 
duration of hemodialysis, age, severity of neuropathic symp-
toms, or severity of neurological deficits caused by peripher-
al neuropathy.
Our findings indicate a high prevalence of autonomic dys-
function in patients with end-stage renal failure (62%), with 
the parasympathetic system being more frequently affected 
(50%) than the sympathetic system (28%). Previous studies 
have also found parasympathetic damage in 35-65% of ure-
mic patients, while the sympathetic system was affected in 
18-24%.
4,7,12,25 Interestingly, we found no correlation between 
the duration of dialysis and the presence or the severity of au-
tonomic dysfunction. Previous reports have documented dis-
crepant results regarding the former relationship. More spe-
cifically, certain investigators have found no association be-
tween autonomic damage and the duration of hemodialysis.
2,7 
while others reported that progress of autonomic dysfunction 
exists with progressive uremia, despite regular intermittent 
hemodialysis.
8 This discordance may be attributed to the dif-
ferent duration of nephropathy prior to the commencement 
of hemodialysis.
The age of our patients was not correlated with the incidence 
of ANS dysfunction. Other studies have also shown that age 
is not a significant contributing factor to dysfunction.
4,7 In 
contrast, Vita et al.
12 concluded that autonomic damage is 
more extensive in elderly patients with uremia on intermit-
tent hemodialysis than in middle-aged patients. Their find-
ings are not incompatible with our results, since the mean age 
of our population was 46 years, while the “elderly group” in 
the previous study had a mean age of 71 years.
We found no correlation between ANS involvement and so-
matic large-nerve fiber function. A similar observation indi-
cating that autonomic involvement is not associated with dys-
function of somatic nerve fibers in CRF patients has been 
reported previously.
5,7,8 However, a positive correlation be-
tween baroreflex sensitivity and motor conduction velocities 
was found previously.
26 Although the basic mechanism un-
derlying axonal dysfunction in uremic neuropathy is not be-
lieved to differ between somatic and autonomic nerves,
8 a dif-
ferent susceptibility of autonomic (small and mostly unmy-
elinated) and peripheral somatic (large and myelinated) nerve 
fibers to uremic toxins is possible, and may account for the 
lack of correlation between autonomic and peripheral nerve 
dysfunction in our series.
The lack of an association between the impaired thermal 
thresholds and ANS damage-despite both functions being 
mediated by small myelinated and unmyelinated fibers-is 
difficult to explain. A plausible explanation may be related to 
the measurement of thermal thresholds, which is based on psy-
chophysical tests, being of little value as a screening test in in-
dividuals with CRF.
27 In addition, since we did not assess cog-
nitive function in our patients, it is probable that our results are 
not precise due to the method used to measure thermal thresh-
Table 3. Incidence of autonomic dysfunction in different patient groups
Overall Normal AF Abnormal AF p
ANSS Normal
Abnormal
25
17
10
02
15
15
0.048
NSS Normal
Abnormal
18
24
04
08
14
16
NS
NDS Normal
Abnormal
24
18
07
05
17
13
NS
WT Normal
Abnormal
31
10
09
03
22
07
NS
CT Normal
Abnormal
38
03
12
00
26
03
NS
NCSs Normal
Abnormal
16
25
03
09
13
16
NS
AF: autonomic function, NS: not significant, ANSS: Autonomic Neuropathy Symptom Score, NSS: Neuropathy Symptoms Score, NDS: 
Neuropathy Disability Score, WT: warm threshold, CT: cold threshold, NCSs: nerve conduction studies. Stamboulis E et al.
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olds. Moreover, the trophic skin changes and ankle edema that 
are frequently encountered in these patients, may have influ-
enced the evaluations of this clinical test. Finally, a difference 
in sensitivity between thermal sensations and ANS function 
cannot be excluded on the basis of our findings.
Certain limitations of the present report need to be acknowl-
edged. First, although the investigators performing the auto-
nomic function tests were unaware of the patients’ medical 
histories, it could be argued that the examiner were not blind-
ed to the clinical signs of the disease, including skin pallor, 
jaundice, or bone deformities. Second, given the relatively 
small sample, a type II error cannot be excluded. Third, the 
cross-sectional design of the present study limits our ability 
to establish any cause-effect relationships between autonomic 
dysfunction and peripheral neuropathy. For instance, it should 
be kept in mind that arterial calcification may contribute to 
autonomic dysfunction by reducing baroreceptor sensitivity,
28 
and this potential confounder was not included in our analy-
ses. Moreover, since hyperparathyroidism has been suggest-
ed to play a role in the development of uremic autonomic dys-
function,
29 our omission of not measuring parathormone levels 
in our patients should be considered another methodological 
shortcoming of the present study. Finally, although autonom-
ic dysfunction was highly prevalent in our series, it should be 
noted that CV autonomic reflexes were only mildly affected 
in most patients. In conclusion, similar to other studies, we 
found a high prevalence of dysfunction in patients with CRF 
on hemodialysis. However, the severity of that autonomic dys-
function was not related to older age, longer duration of he-
modialysis, and presence or severity of large- as well as small-
fiber peripheral neuropathy.
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